BUROSUMAB
burosumab 10 mg/mL injection, 1 mL vial
BUROSUMAB (13163T)
13163T
Manner of administration:Injection
Restriction
Indication: X-linked hypophosphataemia
Treatment phase: Initial treatment - New patient
Restriction
Indication: X-linked hypophosphataemia
Treatment phase: Continuing treatment
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 1 | # of repeats: 5 | DPMQ: $4,047.88 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Crysvita | |||||